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Voltage-dependent anion channels (VDACs) have originally been characterized as mitochondrial
porins. Starting in the late 1980s, however, evidence began to accumulate that VDACs can also be
expressed in plasma membranes. In this review, we brieﬂy revisit the historical milestones in the
discovery of plasma membrane-bound VDAC, and we critically analyze the evidence for VDAC
plasma membrane localization obtained from various puriﬁcation strategies and recently from
plasma membrane proteomics studies. We discuss the possible biological function and relevance
of VDAC in the plasma membrane and ﬁnally discuss a hypothetical model of how VDAC may be tar-
geted to the plasma membrane.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
It was at the 1989 Bari-meeting on ‘‘Structure Function and Bio-
genesis of Energy Transfer Systems” organized by Ernesto Quaglia-
rello that the then shocking surprise arose. A German scientist,
Friederich P. Thinnes, reported the whole sequence determined
by Edman degradation and the plasma membrane localization of
the human porin 31HL, later identiﬁed as the Voltage-dependent
anion-selective channel, isoform 1 (VDAC1) [1,2]. Both achieve-
ments are milestones in the ﬁeld of VDAC research, since this
was the ﬁrst protein sequence obtained for this class of channels
(thus a reference for the next sequences deduced by genetic recom-
binant technology) and it was the ﬁrst proposal of the presence of
this pore outside its most acknowledged mitochondrial location.
VDACs, also known as mitochondrial porins, are abundant pro-
teins found in the outer mitochondrial membrane (OMM). Theychemical Societies. Published by E
ydroxylapatite; MAMs, mito-
chondrial membrane; PAMs,
esis of b-barrel membrane
; VDAC, voltage dependent
e Pinto), +61 3 9902 9500 (A.
, alfons.lawen@med.monash.
o), http://www.med.monash.form the pores that allow the diffusion of small hydrophilic solutes
through the membrane (for reviews see [3,4]). Research on VDAC
for a long time has been regarded as niche-research since the outer
mitochondrial membrane was considered just an envelope lacking
any selectivity. In the 1980’s and 1990’s extensive functional stud-
ies allowed its electrophysiological characterization, leading to a
unifying view of VDAC as a protein possessing extremely con-
served structural and functional features across species (despite
major differences in the sequence), because of an obviously impor-
tant role [5]. The electrophysiological characterization justiﬁes the
deﬁnition of VDAC as a voltage-dependent channel: in vitro this
pore has the ability to sense the electrical potential imposed onto
the membrane and reacting to it with a partial closure [6,7]. The
diameter of the VDAC pore was estimated to be around 1.7 nm.
In 2008 the structure of VDAC has been determined by several
groups [8–10] and was shown to be a b-barrel composed of 19
antiparallel b-strands with a pore cavity calculated to be
27  14 Å in the narrowest point of the channel [10].
2. The discovery of VDAC in plasma membrane
Thinnes and co-workers fortuitously puriﬁed porin from human
B-lymphocytes in the course of the isolation of human transplanta-
tion antigens of class II. They encountered astonishing high
amounts of a 31 kDa protein in enriched plasma membranes of hu-
man B-lymphocytes and ﬁrst sequence data showed that it was an
unknown protein. As Thinnes writes, ‘‘endeavors to get a ﬁrst cluelsevier B.V. All rights reserved.
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www.futhin.de/).
Intrigued by this unexpected protein, the group decided to get a
complete sequence. The structural work demonstrated that the un-
known protein was a porin, now named ‘‘porin 31HL” and later
found to have a sequence identical with that of human VDAC
[11]. Antibodies against the most antigenic region of the protein,
the very ﬁrst 11 N-terminal amino acids [12], were developed by
the same group and used in two kinds of experiments: topological
studies aimed at detecting the transmembrane orientation of the
mitochondrial VDAC (for a review see [13]) and generation of, usu-
ally, secondary immunoﬂuorescence images of various cell sur-
faces [14].
This ﬁnding was subsequently conﬁrmed by a number of stud-
ies employing several cell lines or tissues (normal and cultured
lymphocytes [15,16], epithelial cells [17], astrocytes [18], the
post-synaptic membrane fraction from brain [19]) and ﬂow cytom-
etry as well as EM immunogold labelling and immunoﬂuorescence
techniques. Immunoﬂuorescence showed a punctuate staining dis-
tribution on the cell surface, compatible with a localization in
membrane subdomains of the protein.
The weak point of this line of evidence is that all immuno-topo-
logical evidence was obtained by the same set of anti-VDAC anti-
bodies and by histochemical techniques alone [20]. Tag-modiﬁed
porin cDNAs were used to transfect cultured cells and the intracel-
lular target of each porin isoform was studied by subcellular frac-
tionation, light level immunocytochemistry and immunoelectron
microscopy. The authors concluded that the data supporting a
non-mitochondrial localization of VDAC1 were likely to be artifacts
due probably to unspeciﬁc immunoreactions and redistribution of
porin among subcellular fractions in procedures involving the use
of detergents [21].
New biochemical evidence supporting the presence of porin in
plasma membrane came from other groups. Lisanti et al. [22] re-
ported the presence of VDAC1 in a catalogue of proteins identiﬁed
in caveolae. Caveolae are domains of the plasma membrane where
speciﬁc lipids and proteins are subcompartmentalized. A family of
proteins termed caveolins organizes these membranous domains
that have speciﬁc functions in the trafﬁcking between the plasma
membrane and the rest of the cell. Recent proteomic surveys have
conﬁrmed the presence of VDAC(s) in the plasma membrane of hu-
man cells [23–25]. Interestingly it has been observed that the
expression level in this compartment can be modiﬁed in patholog-
ical situations ([26] and see below).3. Puriﬁcation of VDAC from plasma membrane: proofs of the
localization
To deﬁnitely establish the presence of VDAC in the plasma
membrane, its puriﬁcation from that compartment and the func-
tional comparison with the authentic VDAC from mitochondria
was attempted. This difﬁcult task had to face the notion that the
VDAC protein localized in the two different compartments had
the same structure and thus any tool targeting one of them would
not be able to distinguish between the two. Jakob et al. [27]
labelled intact cells with the membrane-impermeant reagent
NH-SS-biotin and showed that the 2D-pattern of avidin-labelled
protein overlapped the pattern obtained by immunodecoration of
cell extracts from human human multiple meyloma KM3cells with
anti-VDAC speciﬁc antibodies [27]. Thus the plasma membrane
VDAC could be segregated from the mitochondrial VDAC on the ba-
sis of the assumption that NH-SS-biotin could react only with pro-
tein segments exposed to the external surface of the plasma
membrane. On that basis, a puriﬁcation protocol was designed
[28] to label intact human human T lymphoid-like CEM cells withNH-SS-biotin and to isolate caveolae, since this PM subcompart-
ment was reported to be enriched in VDAC1 [22]. This preparation
was at the end puriﬁed by two chromatographic steps. An hydrox-
ylapatite (HTP)/Celite column was used to isolate porin from other
membrane proteins [28]; next an afﬁnity puriﬁcation step on
streptavidin-agarose was used to separate VDAC1 protein labelled
with NH-SS-biotin. This procedure thus allows for the puriﬁcation
of VDAC1 that is genuinely located in the plasma membrane.
(Fig. 1A) [29]. This procedure resulted in a single protein band in
sodium dodecylsulfate polyacrylamide gel electrophoresis, which
was identiﬁed as VDAC1 on the basis of its electrophoretic mobil-
ity, reactivity with polyclonal and monoclonal antibodies, and
reconstitution experiments in planar bilayers that displayed the
typical porin electrophysiological activity after reconstitution [30].
In another puriﬁcation protocol, aiming at the puriﬁcation of
NADH:ferricyanide reductase activity, human Namalwa cells were
harvested and washed, and the plasma membrane extracted to a
purity of 90%. Triton X-100 was used to solubilize maximal enzyme
activity. To further purify the protein, the solubilized membrane
proteins were chromatographed through a DEAE-Sephacel column
and next a Blue Sepharose or 20,50-ADP afﬁnity column. The frac-
tions with NADH:ferricyanide reductase activity were then precip-
itated and run in an sodium dodecylsulfate polyacrylamide gel
electrophoresis. A 35-kDa band correlated with enzyme activity,
suggesting it might be the NADH-ferricyanide reductase [31]
(Fig. 1B).
The plasma membrane material was also puriﬁed according to
the established puriﬁcation protocol for mitochondrial VDAC by
detergent solubilization and a single step chromatography on
HTP/Celite [31]. The protein puriﬁed with these two different pro-
cedures resulted to be identical both from the chemical and func-
tional point of view.4. Functional features of VDAC in the plasma membrane
The presence of VDAC in the plasma membrane was considered
to be a kind of oddity, since a large, unspeciﬁc pore in the plasma
membrane would be expected to be lethal to the cell [20]. How-
ever, considering the resting membrane potential across the plas-
ma membrane of about 30 to 60 mV [32–34], VDAC1 in the
plasma membrane will be in the closed state most of the time
[35]. Furthermore, VDACs show altered gating behaviour in re-
sponse to micromolar concentrations of b-NADH [36]. VDAC is
more sensitive to changes in applied voltage in the presence of
NADH [36]. Therefore, in the presence of a transmembrane poten-
tial of either polarity, cytosolic NADH concentrations will promote
the closure of VDAC. As discussed in the previous section, many
groups now have found VDACs in the plasma membrane and con-
sidering the above discussion, one can assume that VDACs in the
plasma membrane are not lethal and will have some biologically
relevant function.
There are several proposals in the literature claiming functional
roles for VDAC in the plasma membrane. The presence of channels
in the plasma membrane has been suggested to be somehow re-
lated to the VDAC protein. When VDAC1 was over-expressed in
mouse airway epithelial cells, these cells increased their ATP re-
lease as compared to the parent cells. On the other hand, ﬁbro-
blasts in which VDAC1 was deleted showed a clearly decreased
level of ATP release into the medium. Plasma membrane VDAC1
also facilitated regulatory volume decrease in epithelial cells. It
was therefore concluded that VDAC plays a role in cellular ATP re-
lease and volume control [37]. VDAC has long been suggested to be
the plasma membrane maxi-anion channel, based on the similar
conductance and gating characteristics of the two channels [38].
Bahamonde et al. [39] showed that plasma membrane-localized
Fig. 1. Puriﬁcation procedures for VDAC1 from the plasma membrane. (A) CEM cells were incubated with NH-SS-biotin, disrupted and the caveolae were isolated [28]. After
solubilisation in 10% Triton X-100 and centrifugation, the material was puriﬁed by HTP/Celite chromatography, followed by an afﬁnity puriﬁcation step on streptavidin-
agarose. (B) General strategies used in [28–30] (a) and [31] (b and c).
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nels in neuroblastoma cells and that silencing of plasmamembrane
VDAC1 results in a decrease in anti-oestrogen-activated maxi-chlo-
ride currents. From these data the authors concluded that plasma
membrane VDAC1 either is identical to the maxi-anion channel
or must be a part of it. This claim, however, was recently rejected
in a study by Sabirov et al. [40], who could not establish any corre-
lation between VDAC expression and maxi-anion channel activity
in mouse ﬁbroblasts in which they knocked out the three VDAC
isoforms individually and in combination. The current status of
the debate considering VDAC1 as the maxi-anion channel of the
plasma membrane is discussed in more detail in a recent review
[41]. Furthermore, plasma membrane-localized VDAC1 has been
suggested to be, at least part of the volume-regulated anion chan-
nel, VRAC [42].
As discussed in the previous section, plasma membrane VDAC1
appears to be enriched in caveolae. In neurons, plasma membrane
VDAC1 in these caveolae associates with plasma membrane oest-
rogen receptor a. Antibodies directed against the N-terminus of
human VDAC1 can prevent b-amyloid-induced neurotoxicity,
when applied before cells are challenged with the b-amyloid pep-tide [26], indicating that VDAC1 may be a negative regulator of the
oestrogen receptor a, which was reported to be neuroprotective
[26].
We have recently proposed that plasma membrane VDAC1 can
function as a redox enzyme, capable of reducing extracellular fer-
ricyanide in the presence of intracellular NADH [31]. The presence
of an NADH:ferricyanide reductase in the plasma membrane is
suggested by the ﬁnding that oxidation of cytosolic NADH causes
concomitant reduction of ferricyanide, an artiﬁcial membrane-
impermeant electron acceptor [43,44]. This enzymatic activity is
referred to as plasma membrane NADH-oxidoreductase (PMOR).
The puriﬁcation of a protein associated with NADH:ferricyanide
reductase activity from Namalwa cells led to its identiﬁcation as
human VDAC1. Evidence for this result came from matrix-assisted
laser desorption ionization time-of-ﬂight (MALDI-TOF) analysis,
immunoprecipitation and puriﬁcation using different methods
[31,45]. To conﬁrm that the plasma membrane ferricyanide reduc-
tase is identical with VDAC1, we obtained a vector expressing mur-
ine VDAC1 tagged with GFP and having a leader sequence targeting
it to the plasma membrane (plVDAC1-GFP; [46]). Transfection of
COS-7 cells with the vector resulted in a 40-fold increase of their
1796 V. De Pinto et al. / FEBS Letters 584 (2010) 1793–1799plasma membrane NADH:ferricyanide reductase activity [31].
Although it seems unlikely that VDAC1 would function as a reduc-
tase in mitochondria, there have been two recent reports claiming
that mitochondrial VDAC1 is functional as an NADH-dependent
reductase. A ﬁrst report suggested that mitochondrial VDAC1’s
reductase activity is responsible for the reductive activation of qui-
none anticancer drugs like 2-methyl-furanonaphthoquinone and
2-methyl-5-hydroxy-furanonaphthoquinone [47]; a second report
claimed that it is VDAC1’s NADH:paraquat reductase activity in
the mitochondria that is responsible for paraquat toxicity [48].
As discussed above, NADH can regulate the gating of VDAC [36]
and adenosine nucleotides can be transported by the molecule
[49]. Nucleotide-binding sites in VDAC1 have been mapped by sev-
eral investigators [6,31,50], however, ﬁnal molecular biological
identiﬁcation of the exact NADH-binding site is still outstanding.
Though the NADH:ferricyanide reductase activity has been re-
ported in several publications following our initial ﬁnding
[47,48,51–54], none of these publications actually shows that
homogenous VDAC is enzymatically active. Considering the prob-
lems of some laboratories to measure the activity, other possible
explanations for the above ﬁndings, are that the VDAC prepara-
tions tested were contaminated with an enzyme capable of cata-
lyzing electron transfer from NADH to ferricyanide and/or that
over-expression of VDAC1 in the plasma membrane resulted in
the release of a reductant into the medium capable of reducing fer-
ricyanide, similar to recent data reported by us for the reduction of
iron citrate by ascorbate released from cells [55]. Thus a ﬁnal proof
of VDAC1’s function as an enzyme is still outstanding.
Other possible roles for VDAC1 in the plasma membrane have
been proposed. VDAC1 was identiﬁed in the plasma membrane
of human endothelial cells and described as the receptor for plas-
minogen kringle 5. Kringle 5 binds to these cells with high afﬁnity
and this binding is inhibited by antibodies directed against the
kringle 5 binding domain of VDAC1 [56]. Based upon its speciﬁc
binding of a neuro-active steroid analogue and its immuno-copre-
cipitation with the b2 and b3 subunits of the c-aminobutyric acid
type A (GABAA) receptor, VDAC1 was proposed to be part of the
GABAA receptor in rat brain membranes [57]. Using knockout cells
of the three VDAC isoforms, the steroid analogue was shown to
also bind to plasma membrane VDAC2, but binding to either
VDAC1 or VDAC2 was found to be modulating the steroid effect
rather than promoting it [58].
Finally, VDAC1 in the plasma membrane was suggested to be
involved in the regulation of apoptosis and not unlike the data
on the role of mitochondrial VDAC in apoptosis regulation, the data
are at this stage highly controversial. Our initial preliminary data
on plasma membrane VDAC1 transfected cells indicated a protec-
tive role for plasma membrane VDAC1 in apoptosis [59]. Elinder
et al. [51], however, reported plasma membrane VDAC1 activation
during neuronal apoptosis and showed that extracellularly applied
antibodies directed against VDAC1 were able to prevent apoptosis
and the concomitant stimulation of VDAC1’s ferricyanide reductase
activity. In a follow-up study the authors were able to show, that
the plasma membrane VDAC1 pore is closed in healthy, but open
in apoptotic neurons and that the apoptosis-promoting effect is
speciﬁc for neurons and is not observed in neural stem cells [53],
where VDAC1 is not expressed to high levels in the plasma mem-
brane. Furthermore, VDAC in the plasma membrane has been sug-
gested to be a positive regulator of the extrinsic pathway of
apoptosis in prostate cancer cells [60]. These data indicate that
the effects of VDAC1 on apoptosis may be multiple and cell type-
speciﬁc and that it will be necessary to examine these effects for
each individual cell type.
VDAC1 has also been detected in the sarcoplasmic reticulum of
skeletal muscle [61–64], however, its function in this compartment
is still unknown. Sarcoplasmic reticulum VDAC1 has been sug-gested to be involved in calcium homeostasis and the mitochon-
drial/sarcoplasmic reticular interaction [65].
Finally, while a range of proteomic analyses would suggest
up-regulation of VDACs in cancer, there is a couple of reports
demonstrating that also plasma membrane VDAC1 is involved
in cancer development. Thus, VDAC1 is up-regulated by hypox-
ia-adaptation in murine B16F10 melanoma cells [24] and both
plasma membrane VDAC1 and VDAC2 were reported to be up-
regulated in human pancreatic cancer [25]. As most proteomic
analyses showing up-regulation of VDAC do not analyse its sub-
cellular localization, it can be assumed that some of these reports
deal – at least to some extent – with an up-regulation of plasma
membrane VDAC.
There is much less known about the function of VDAC2 in the
plasma membrane, however, it was recently proposed to play a
role in cellular iron uptake, as it was up-regulated in the plasma
membrane in response to iron deprivation in K562 cells [66].5. Targeting of VDAC to the plasma membrane
Even though the biogenesis of (nuclearly encoded) b-barrel pro-
teins in the OMM has been studied in some detail, this complex
process is still somewhat ill-deﬁned. The present knowledge has
been recently reviewed by others [67,68]. In brief, the VDAC pre-
cursor, containing a non-cleavable mitochondrial targeting se-
quence, is synthesized on cytosolic ribosomes and reaches the
mitochondria, where it is imported by the translocase of the outer
membrane (TOM) complex. Thus, VDAC does not directly insert
into the outer membrane (as it does in reconstituted artiﬁcial sys-
tems). From the TOM complex, the precursor is passed, possibly
with the help of small translocase of the inner membrane (TIM)
proteins that are located in the intermembrane space, to the topo-
genesis of b-barrel membrane proteins (TOB) complex [67] (also
referred to as the ‘‘sorting and assembly machinery [SAM] com-
plex” [68]). It remains, however, unresolved how exactly VDAC is
channeled from the TOM to the TOB complex, how the TOB com-
plex mediates VDAC insertion into the OMM, what the energetics
of this process are and at which point the precursor molecules fold
into their native conformation [68]. The mechanism proposed for
VDAC insertion into the OMM requires initial import of the precur-
sor into the mitochondrial intermembrane space followed by
insertion into the OMM. This process may be so complex in order
to assure that the correct topology of the protein and the correct
directionality of insertion are achieved.
A seminal study by Buettner et al. [46] indicated the existence
of two alternative splice variants of VDAC1 in mice that differ only
by the use of an alternative ﬁrst exon. One splice variant encodes a
cleavable hydrophobic N-terminal leader peptide that directs the
protein through the secretory pathway to the cell surface, while
the other is devoid of a leader peptide and trafﬁcs to the OMM
by default [46]. Evidence for the presence of a plasma mem-
brane-targeting pre-sequence on VDAC1 has also been reported
in C1300 mouse neuroblastoma cells [39]. A similar mechanism
was earlier reported for mitochondrial transcription factor A,
which can be alternatively targeted to the mitochondria or to the
nucleus in spermatocytes and elongating spermatids. Depending
on the presence or absence of a cleavable mitochondrial targeting
sequence, the protein is directed to the mitochondria or to the nu-
cleus [69]. Whereas in the mice VDAC1 gene, an exon encoding for
a secretory pathway signalling peptide can be easily identiﬁed, a
human homologue of such a peptide has not been found yet. Inter-
estingly, however, it appears that such a leader peptide is not nec-
essary for plasma membrane targeting. For example, heterologous
expression of human VDAC1 that has been C-terminally tagged
with enhanced green ﬂuorescent protein (EGFP), in Xenopus laevis
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cell surface [70]. Tagging the N-terminus of VDAC1 with EGFP,
however prevented its expression at the plasma membrane, indi-
cating that the N-terminus is involved in controlling VDAC1
expression at the plasma membrane. Furthermore, these authors
have demonstrated that upon transfection of X. laevis oocytes with
cDNA containing the human VDAC1-coding sequence carrying a
FLAG epitope at the N-terminus but lacking a speciﬁc secretory
pathway signalling sequence, the modiﬁed VDAC1 could still be
detected on the surface of the cells [70]. Such data, however, leave
open the question of a general mechanism for differential VDAC
trafﬁcking.
An alternative, post-translational mechanism for VDAC expres-
sion in non-mitochondrial membranes relies on the notion of dy-
namic membrane protein redistribution. For example, in yeast a
subfraction of the endoplasmic reticulum (ER) is known to be in
close association with mitochondria [71] and plasma membrane
[72]. Similar structures have been described in mammalian tissues,
including rat [73,74] and mouse liver [75]. In addition to a possible
exchange of lipids and/or metabolites between these membrane
systems, an exchange of protein components may also occur. Thus,
it is possible that VDAC may trafﬁc to the ER from the mitochon-
dria, via mitochondria-associated membranes (MAMs) [71], then
to the plasma membrane from the ER, via plasma membrane/ER
associations (PAMs) [72] (Fig. 2). In support of this hypothesis,
VDAC has already been identiﬁed in association to MAMs where
it is thought to contribute to regulating calcium ﬂow between
mitochondria and ER/sarcoplasmic reticulum [76], however, direct
evidence for this mechanism is still missing and its regulation is
not yet well understood. A recent review discusses the possible
mechanisms of dynamic membrane protein redistribution from
mitochondria to the plasma membrane [77].Fig. 2. Hypothetical trafﬁcking of human VDACs to the plasma membrane via MAMs a
complexes (1). VDAC may then trafﬁc to the ER from the mitochondria, via mitochondria-
via plasma membrane/ER associations (PAMs, 3).6. Open questions and conclusions
Though originally considered unlikely to have biological rele-
vance in the plasma membrane, plasma membrane VDAC1 and
VDAC2 have now so frequently observed, that there can be no
doubt that they are expressed at the plasma membrane in vivo.
Considering the facts that a vital cell will have a plasma membrane
potential and some cytosolic NADH, it is very likely that plasma
membrane VDACs are in their closed state for most of the time.
They may however open in response to speciﬁc signals.
Several biological functions have been attributed to plasma
membrane VDACs over the years. In mitochondria it is well estab-
lished that VDAC functions as an anion channel as well as a scaf-
folding protein [5,76]; it is therefore enticing to speculate that
plasma membrane VDACs may also have scaffolding function.
Thus, effects attributed to VDAC may arise from VDAC itself or
from its association with other proteins in the plasma membrane.
As in the mitochondria, VDAC in the plasma membrane may have
the potential to assemble with a range of different proteins and
depending on the complexes formed may have different functions.
It may be worth noting that all the biological functions discussed in
Section 3 are not mutually exclusive.
In mouse there is clear evidence that VDAC1 can be differen-
tially spliced and depending on the ﬁrst exon that is used, will be
targeted to the mitochondrion or the plasma membrane. In hu-
mans, however, where VDAC1 has also been found localized to
the plasma membrane by many different groups (see Sections 1
and 2), no secretory pathway signal peptide has been identiﬁed.
As VDAC will be targeted to the mitochondrial OMM via TOM
and TOB complexes, we consider a membrane trafﬁcking pathway
the most likely explanation for the targeting of human VDAC1 and
2 to the plasma membrane. We propose a pathway involvingnd PAMs. Human VDAC is originally inserted into the OMM via the TOM and TOB
associated membranes (MAMs; 2), and ﬁnally to the plasma membrane from the ER,
1798 V. De Pinto et al. / FEBS Letters 584 (2010) 1793–1799MAMs and PAMs. It will need further research to ﬁnally clarify the
targeting mechanism of VDACs to the plasma membrane without
the use of signal peptides.
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